Kelly Churion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kelly Churion has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Aaron H. Phillips
Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee
10 shared publications - Amit Kumar
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
10 shared publications - Beisi Xu
Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
10 shared publications - Burgess B. Freeman
St. Jude Children's Research Hospital
10 shared publications - Chandra Rolle
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee
10 shared publications - Clive S. D’santos
Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
10 shared publications
Latest Publications
- Open Access
Brewed Coffee and Its Components Act Through Orphan Nuclear Receptor 4A1 (NR4A1)
Background/Objective: Coffee is the most highly consumed beverage worldwide, and coffee drinkers exhibit decreased mortality and protection from aging-related diseases. This study investigates the role of orphan nuclear receptor 4A1 (NR4A1) in mediating the effects of brewed coffee and the major polyphenolic and polyhydroxy compounds in brewed coffee and also in determining their binding to NR4A1. Methods: The interactions of brewed coffee and several of the major individual compounds in brewed coffee with the ligand-binding domain of NR4A1 were determined using a fluorescent binding assay. For specific compounds, binding was also carried out by surface plasmon resonance, and molecular docking studies were also performed. NR4A1-responsive Rh30 cancer cells were used as models to determine NR4A1-dependent transactivation, cell growth inhibition and inhibition of specific gene products, and in some studies, knockdown of NR4A1 by RNA interference was also determined. Inhibition of lipopolysaccharide-induced IkBα by key polyphenolics was also investigated in RAW264.7 macrophages. Results: Brewed coffee and several polyphenolics, including caffeic acid, ferulic acid, chlorogenic acid, p-coumaric acid, several cinnamic acid derivatives, kahweol, and cafestrol, bound NR4A1 in binding assays, and most Kd values were <10 µM. Brewed coffee and the major polyphenolics inhibited growth of NR4A1-responsive Rh30 cells, and this was attenuated in NR4A1-deficient Rh30 cells. These same compounds also exhibited NR4A1-dependent effects on transactivation and gene product responses in Rh30 and RAW264.7 macrophages and exhibited inverse NR4A1 agonist activity. In contrast, the NR4A1-dependent activity of caffeine and quinic acid was highly variable, suggesting that they are selective NR4A1 ligands. Conclusions: The results of this study demonstrate that brewed coffee and its major polyphenolics and polyhydroxy constituents are NR4A1 ligands and that NR4A1 may play an important role in the health-protective effects of coffee. These results, coupled with recent studies, indicate that NR4A1 and its ligands may play an important role in diet and health.
Open AccessBrewed Coffee and Its Components Act Through Orphan Nuclear Receptor 4A1 (NR4A1)
Background/Objective: Coffee is the most highly consumed beverage worldwide, and coffee drinkers exhibit decreased mortality and protection from aging-related diseases. This study investigates the role of orphan nuclear receptor 4A1 (NR4A1) in mediating the effects of brewed coffee and the major polyphenolic and polyhydroxy compounds in brewed coffee and also in determining their binding to NR4A1. Methods: The interactions of brewed coffee and several of the major individual compounds in brewed coffee with the ligand-binding domain of NR4A1 were determined using a fluorescent binding assay. For specific compounds, binding was also carried out by surface plasmon resonance, and molecular docking studies were also performed. NR4A1-responsive Rh30 cancer cells were used as models to determine NR4A1-dependent transactivation, cell growth inhibition and inhibition of specific gene products, and in some studies, knockdown of NR4A1 by RNA interference was also determined. Inhibition of lipopolysaccharide-induced IkBα by key polyphenolics was also investigated in RAW264.7 macrophages. Results: Brewed coffee and several polyphenolics, including caffeic acid, ferulic acid, chlorogenic acid, p-coumaric acid, several cinnamic acid derivatives, kahweol, and cafestrol, bound NR4A1 in binding assays, and most Kd values were <10 µM. Brewed coffee and the major polyphenolics inhibited growth of NR4A1-responsive Rh30 cells, and this was attenuated in NR4A1-deficient Rh30 cells. These same compounds also exhibited NR4A1-dependent effects on transactivation and gene product responses in Rh30 and RAW264.7 macrophages and exhibited inverse NR4A1 agonist activity. In contrast, the NR4A1-dependent activity of caffeine and quinic acid was highly variable, suggesting that they are selective NR4A1 ligands. Conclusions: The results of this study demonstrate that brewed coffee and its major polyphenolics and polyhydroxy constituents are NR4A1 ligands and that NR4A1 may play an important role in the health-protective effects of coffee. These results, coupled with recent studies, indicate that NR4A1 and its ligands may play an important role in diet and health.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 7 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Eltanexor treatment in primary human cells. (A–B) Flow cytometry gating and representative plots related to Figures 5C–E. (C) CellTiter-Glo assay in CD34⁺ cells expressing UBTF-TD or UBTF-TD-NES-M. (D) HOXA/B gene expression heatmap after DMSO, dTAG-13, or eltanexor treatment. (E) UpSet plot showing UBTF-TD and XPO1 gene occupancy changes. (F–G) Design and results of colony-forming assays in UBTF-TD PDX cells treated with eltanexor.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 7 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Eltanexor treatment in primary human cells. (A–B) Flow cytometry gating and representative plots related to Figures 5C–E. (C) CellTiter-Glo assay in CD34⁺ cells expressing UBTF-TD or UBTF-TD-NES-M. (D) HOXA/B gene expression heatmap after DMSO, dTAG-13, or eltanexor treatment. (E) UpSet plot showing UBTF-TD and XPO1 gene occupancy changes. (F–G) Design and results of colony-forming assays in UBTF-TD PDX cells treated with eltanexor.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 6 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Illustrates XPO1 occupancy dynamics in cbCD34⁺ cells over time.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 6 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Illustrates XPO1 occupancy dynamics in cbCD34⁺ cells over time.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S7 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Supplemental Table 1: qPLEX RIME data. Supplemental Table 2: Identification of Nuclear Export Signals in 97 cases of UBTF-TD AML/MDS. Supplemental Table 3: Protein-coding sequences used in protein purification studies. Supplemental Table 4: NES mutation strategy in UBTF-TD constructs. Supplemental Table 5: SPR data Quantification. Supplemental Table 6: qPlEX RIME data Second Run. Supplemental Table 7: Antibodies.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S7 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Supplemental Table 1: qPLEX RIME data. Supplemental Table 2: Identification of Nuclear Export Signals in 97 cases of UBTF-TD AML/MDS. Supplemental Table 3: Protein-coding sequences used in protein purification studies. Supplemental Table 4: NES mutation strategy in UBTF-TD constructs. Supplemental Table 5: SPR data Quantification. Supplemental Table 6: qPlEX RIME data Second Run. Supplemental Table 7: Antibodies.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Displays representative sensograms illustrating the binding of XPO1/RanGTP–RanBP1 to surface-bound cargo proteins at varying concentrations.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Displays representative sensograms illustrating the binding of XPO1/RanGTP–RanBP1 to surface-bound cargo proteins at varying concentrations.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Illustrates chromatin protein interactions involving UBTF-TD54–NES-M in K562 cells using qPLEX-RIME. Panel A outlines the experimental design. Panels B and C present volcano plots comparing UBTF-TD54–NES-M to UBTF-WT and NES-M, respectively.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Illustrates chromatin protein interactions involving UBTF-TD54–NES-M in K562 cells using qPLEX-RIME. Panel A outlines the experimental design. Panels B and C present volcano plots comparing UBTF-TD54–NES-M to UBTF-WT and NES-M, respectively.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 8 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Flow cytometry analysis in UBTF-TD PDX models. (A) Gating strategy for peripheral blood and bone marrow used in Figures 6 and 7. (B–C) Representative plots and summary of peripheral blood chimerism following eltanexor treatment. (D–E) Representative flow cytometry plots from Figures 6D and 7E.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 8 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Flow cytometry analysis in UBTF-TD PDX models. (A) Gating strategy for peripheral blood and bone marrow used in Figures 6 and 7. (B–C) Representative plots and summary of peripheral blood chimerism following eltanexor treatment. (D–E) Representative flow cytometry plots from Figures 6D and 7E.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Depicts genomic occupancy of HA-tagged UBTF constructs and XPO1 at rDNA loci in cbCD34⁺ cells using CUT&RUN.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Depicts genomic occupancy of HA-tagged UBTF constructs and XPO1 at rDNA loci in cbCD34⁺ cells using CUT&RUN.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Shows String-DB analyses comparing protein enrichment in UBTF-TD versus UBTF-WT qPLEX-RIME datasets. Panel A highlights biological processes associated with commonly enriched proteins, while Panel B focuses on processes linked to proteins specifically enriched in UBTF-TD.
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Shows String-DB analyses comparing protein enrichment in UBTF-TD versus UBTF-WT qPLEX-RIME datasets. Panel A highlights biological processes associated with commonly enriched proteins, while Panel B focuses on processes linked to proteins specifically enriched in UBTF-TD.
- Open Access
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Panel A shows western blot analysis (anti-HA) of cbCD34⁺ cell lysates transduced with various HA-tagged UBTF constructs and vector control. Panel B presents RNA-seq tracks visualized in IGV, highlighting soft-clipped reads that indicate tandem duplications and the expressed cDNA sequences. Panel D-F depict gating strategies and representative flow plots
- 12 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Panel A shows western blot analysis (anti-HA) of cbCD34⁺ cell lysates transduced with various HA-tagged UBTF constructs and vector control. Panel B presents RNA-seq tracks visualized in IGV, highlighting soft-clipped reads that indicate tandem duplications and the expressed cDNA sequences. Panel D-F depict gating strategies and representative flow plots